enVVeno Medical Corporati...

NASDAQ: NVNO · Real-Time Price · USD
4.54
0.04 (0.89%)
At close: Aug 15, 2025, 9:45 AM

enVVeno Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 546K 525K 452.91K
Gross Profit
n/a -546K -525K -452.91K
Operating Income
-23.83M -25.24M -24.93M -16.89M
Interest Income
389K 180K 161K 19K
Pretax Income
-21.82M -23.52M -24.67M -16.53M
Net Income
-21.82M -23.52M -24.3M -16.2M
Selling & General & Admin
11.58M 11.65M 15.02M 11.16M
Research & Development
12.25M 13.58M 9.91M 5.73M
Other Expenses
n/a n/a n/a 33.27K
Operating Expenses
23.83M 25.24M 24.93M 16.89M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 25.24M 24.93M 16.89M
Income Tax Expense
n/a n/a -365K -331.41K
Shares Outstanding (Basic)
17.14M 12.3M 11.23M 8.68M
Shares Outstanding (Diluted)
17.14M 12.3M 11.23M 8.68M
EPS (Basic)
-1.27 -1.91 -2.16 -1.87
EPS (Diluted)
-1.27 -1.91 -2.16 -1.87
EBITDA
-21.29M -25.02M -24.51M -16.75M
EBIT
n/a -25.24M -24.67M -16.89M
Depreciation & Amortization
n/a 220K 525K 452.91K